Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score Matched Analysis

INTRODUCTION: Basal-bolus (BB) regimens are generally used to intensify basal insulin therapy in patients with type 2 diabetes (T2D) not meeting glycemic targets. However, drawbacks include multiple injection burden and risk of weight gain and hypoglycemia. A once-daily titratable fixed-ratio combin...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabák, Ádám G., Anderson, John, Aschner, Pablo, Liu, Minzhi, Saremi, Aramesh, Stella, Peter, Tinahones, Francisco J., Wysham, Carol, Meier, Juris J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965545/
https://www.ncbi.nlm.nih.gov/pubmed/31848983
http://dx.doi.org/10.1007/s13300-019-00735-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965545/
https://www.ncbi.nlm.nih.gov/pubmed/31848983
http://dx.doi.org/10.1007/s13300-019-00735-7

Ejemplares similares